Detalhe da pesquisa
1.
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study).
Int J Antimicrob Agents
; 63(1): 107049, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38056572
2.
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study).
EClinicalMedicine
; 57: 101895, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36936403